IL6R and systemic inflammatory response syndrome: Our results showed that IL‐6R blockade prominently decreased both BUN and creatinine levels, and mitigated histological alterations in kidney tissue from LPS‐induced SIRS mice, indicating the improvement of renal dysfunction in SIRS.